| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$4,112 ) |
| | 2023 | 2019 | FONDATION VOIR ET ENTENDRE | INSTITUT DE LA VISION | PARIS | | | | FRA | R21EY031117 | Translational models of photoreceptor degeneration to test safety and efficacy of stem celltransplantation | 000 | 1 | NIH | 5/15/2023 | -$4,112 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | FONDATION VOIR ET ENTENDRE | INSTITUT DE LA VISION | PARIS | ILE-DE-FRANCE | | | FRA | R21EY031117 | Translational models of photoreceptor degeneration to test safety and efficacy of stem celltransplantation | 000 | 1 | NIH | 7/19/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | FONDATION VOIR ET ENTENDRE | INSTITUT DE LA VISION | PARIS | ILE-DE-FRANCE | 75012 | | FRA | R21EY031117 | Translational models of photoreceptor degeneration to test safety and efficacy of stem celltransplantation | 000 | 1 | NIH | 1/16/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $214,941 ) |
| | 2019 | 2019 | FONDATION VOIR ET ENTENDRE | INSTITUT DE LA VISION | PARIS | ILE-DE-FRANCE | 75012 | | FRA | R21EY031117 | Translational models of photoreceptor degeneration to test safety and efficacy of stem celltransplantation | 000 | 1 | NIH | 8/1/2019 | $214,941 |
|
|
